193 related articles for article (PubMed ID: 23280128)
1. Thrombin stimulation of inflammatory breast cancer cells leads to aggressiveness via the EGFR-PAR1-Pak1 pathway.
Ohshiro K; Bui-Nguyen TM; Divijendra Natha RS; Schwartz AM; Levine P; Kumar R
Int J Biol Markers; 2012 Dec; 27(4):e305-13. PubMed ID: 23280128
[TBL] [Abstract][Full Text] [Related]
2. The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.
Fujimoto D; Hirono Y; Goi T; Katayama K; Matsukawa S; Yamaguchi A
BMC Cancer; 2010 Aug; 10():443. PubMed ID: 20723226
[TBL] [Abstract][Full Text] [Related]
3. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
[TBL] [Abstract][Full Text] [Related]
4. Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion.
Arora P; Cuevas BD; Russo A; Johnson GL; Trejo J
Oncogene; 2008 Jul; 27(32):4434-45. PubMed ID: 18372913
[TBL] [Abstract][Full Text] [Related]
5. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
[TBL] [Abstract][Full Text] [Related]
6. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
Barnes CJ; Bagheri-Yarmand R; Mandal M; Yang Z; Clayman GL; Hong WK; Kumar R
Mol Cancer Ther; 2003 Apr; 2(4):345-51. PubMed ID: 12700278
[TBL] [Abstract][Full Text] [Related]
7. A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis.
Wang D; Paria BC; Zhang Q; Karpurapu M; Li Q; Gerthoffer WT; Nakaoka Y; Rao GN
Circ Res; 2009 May; 104(9):1066-75. PubMed ID: 19359598
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion.
Victor BC; Anbalagan A; Mohamed MM; Sloane BF; Cavallo-Medved D
Breast Cancer Res; 2011; 13(6):R115. PubMed ID: 22093547
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
10. Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signaling.
Ohshiro K; Schwartz AM; Levine PH; Kumar R
PLoS One; 2012; 7(1):e30725. PubMed ID: 22295107
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer.
Zhang D; LaFortune TA; Krishnamurthy S; Esteva FJ; Cristofanilli M; Liu P; Lucci A; Singh B; Hung MC; Hortobagyi GN; Ueno NT
Clin Cancer Res; 2009 Nov; 15(21):6639-48. PubMed ID: 19825949
[TBL] [Abstract][Full Text] [Related]
12. Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.
Sauer SJ; Tarpley M; Shah I; Save AV; Lyerly HK; Patierno SR; Williams KP; Devi GR
Carcinogenesis; 2017 Mar; 38(3):252-260. PubMed ID: 28426875
[TBL] [Abstract][Full Text] [Related]
13. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
14. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation.
Kaufmann R; Henklein P; Henklein P; Settmacher U
Oncol Rep; 2009 May; 21(5):1261-7. PubMed ID: 19360302
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
16. PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation.
Wu DW; Wu TC; Chen CY; Lee H
Clin Cancer Res; 2016 Nov; 22(21):5370-5382. PubMed ID: 27178741
[TBL] [Abstract][Full Text] [Related]
17. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase.
Adam L; Vadlamudi R; Kondapaka SB; Chernoff J; Mendelsohn J; Kumar R
J Biol Chem; 1998 Oct; 273(43):28238-46. PubMed ID: 9774445
[TBL] [Abstract][Full Text] [Related]
18. Thrombin promotes PAI-1 expression and migration in keratinocytes via ERK dependent Smad linker region phosphorylation.
Talati N; Kamato D; Piva TJ; Little PJ; Osman N
Cell Signal; 2018 Jul; 47():37-43. PubMed ID: 29577978
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of protease-activated receptor 1 and integrin ανβ5 in thrombin-mediated lung cancer cell invasion.
Zhu L; Wang X; Wu J; Mao D; Xu Z; He Z; Yu A
Oncol Rep; 2012 Aug; 28(2):553-60. PubMed ID: 22665038
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.
Hillyer RL; Sirinvasin P; Joglekar M; Sikes RA; van Golen KL; Nohe A
Clin Exp Metastasis; 2012 Dec; 29(8):971-9. PubMed ID: 22610818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
